Last reviewed · How we verify

NCT05023135

DeepView SnapShot Portable (DV-SSP): Device Training Study

Completed Last updated 6 March 2024
What this trial tests

trial testing DeepView SnapShot Portable (DV-SSP) in Burns in 251 participants. Completed in 30 April 2023.

Timeline
7 September 2021
Primary endpoint
9 April 2023
30 April 2023

Quick facts

Lead sponsorSpectralMD
StatusCompleted
Study typeOBSERVATIONAL
Enrollment251
Start date7 September 2021
Primary completion9 April 2023
Estimated completion30 April 2023
Sites11 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

SpectralMD

Who can join

Eligibility, any sex, with Burns or Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. 565 Complications and Outcomes for Electrical Burn Admissions
    · 2025
  2. 566 Covariate Analysis of Performance of Multi-Spectral Imaging System Augmented with Artificial Intelligence
    · 2025

Verify or expand the search:

Other trials of DeepView SnapShot Portable (DV-SSP)

Trials testing the same drug.

Other recruiting trials for Burns

Currently open trials in the same condition.

Other SpectralMD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05023135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing